Home
About
Services
Partners
Client Portfolio
News
Contact
Bank of America drops ‘Merrill Lynch’ name in rebranding effort
February 25, 2019
Trump talk that U.S.-China trade deal near pushes Wall St. higher
February 25, 2019
0
GE inks $21 billion biopharma sale to Danaher in U-turn under Culp
Published by
Muller&Green
at
February 25, 2019
Categories
RSS
Tags
General Electric said on Monday it would sell its biopharma business to Danaher Corp for $21.4 billion in the biggest strategy reversal since Lawrence Culp took over as the industrial conglomerate’s chief executive in September.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more